Lung cancer diagnosed in pilot UK Lung Cancer Screening (UKLS)
| UKLS case No | Baseline nodule category* | Sex | Age | TNM | Final Stage | Diagnosis | Treatment |
|---|---|---|---|---|---|---|---|
| 1 | 4 | M | 59 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 2 | 4 | M | 66 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 3 | 4 | M | 66 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 4 | 4 | M | 55 | pT1b pN0 | IA | Adenocarcinoma | Surgery |
| 5 | 4 | M | 63 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 6 | 4 | F | 64 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 7 | 4 | M | 67 | pT1b pN0 | IA | Small cell carcinoma | Surgery/chemotherapy |
| 8 | 4 | M | 62 | pT1a pN0 | IA | Squamous cell carcinoma | Surgery |
| 9 | 4 | M | 68 | pT1b pN0 | IA | Squamous cell carcinoma | Surgery |
| 10 | 4 | M | 67 | pT1a pN0 | IA | Squamous cell carcinoma | Surgery |
| 11 | 4 | M | 73 | pT1b pN0 | IA | Squamous cell carcinoma | Surgery |
| 12 | 4 | M | 71 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 13 | 4 | M | 72 | cT1b cN0 cM0 | IA | Adenocarcinoma | Radiotherapy |
| 14 | 4 | M | 64 | pT1b pN0 | IA | Adenocarcinoma | Surgery |
| 15 | 4 | M | 68 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 16 | 4 | M | 74 | cT1a cN0 cM0 | IA | Bronchogenic carcinoma | Palliative |
| 17 | 4 | M | 69 | pT1a pN0 | IA | Squamous cell carcinoma | Surgery |
| 18 | 4 | M | 70 | pT2a pN0 | IB | Adenocarcinoma | Surgery |
| 19 | 4 | M | 67 | pT2a pN0 | IB | Adenocarcinoma | Surgery |
| 20 | 4 | M | 68 | pT2a pN1 | IIA | Squamous cell carcinoma | Surgery/chemotherapy |
| 21 | 4 | F | 67 | pT1a pN1 | IIA | Squamous cell carcinoma | Surgery/chemotherapy |
| 22 | 4 | F | 64 | pT2b pN0 | IIA | Adenocarcinoma | Surgery/chemotherapy |
| 23 | 4 | F | 73 | pT2a pN1 | IIA | Small cell carcinoma | Surgery/chemotherapy |
| 24 | 4 | M | 63 | pT1a pN1 | IIA | Adenocarcinoma | Surgery/chemotherapy |
| 25 | 4 | M | 75 | pT2a pN1 | IIA | Squamous cell carcinoma | Surgery/chemotherapy |
| 26 | 4 | M | 64 | pT2b pN0 | IIA | Carcinoid | Surgery |
| 27 | 4 | M | 68 | pT1a pN2 | IIIA | Adenocarcinoma | Surgery |
| 28 | 4 | F | 69 | pT1b pN2 | IIIA | Adenocarcinoma | Surgery/chemotherapy |
| 29 | 4 | M | 63 | cT1a cN2 cM0 | IIIA | Small cell carcinoma | Chemotherapy |
| 30 | 4 | F | 60 | pT3 pN0 | IIB | Squamous cell carcinoma | Surgery/radiotherapy |
| 31 | 4 | M | 66 | cT4 cN3 cM1b | IV | Adenocarcinoma | Chemotherapy/radiotherapy |
| 32 | 4 | M | 64 | cT3 cN2 cM1b | IV | Squamous cell carcinoma | Palliative |
| 33 | 3 (3 months) | M | 68 | pT1a pN0 | IA | Adenocarcinoma (two primaries) | Surgery |
| 34 | 3 (12 months) | M | 69 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 35 | 3 (12 months) | M | 61 | pT1a pN0 | IA | Squamous cell carcinoma | Surgery |
| 36 | 3 (12 months) | M | 70 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 37 | 3 (3 months) | F | 70 | pT1aNx† | IA | Adenocarcinoma | Surgery |
| 38 | 3 (12 months) | M | 66 | pT1b pN0 | IA | Squamous cell carcinoma | Surgery |
| 39 | 3 (12 months) | F | 69 | cT1a cN0 cM0 | IA | Adenocarcinoma | Radiotherapy |
| 40 | 3 (12 months) | M | 71 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
| 41 | 3 (12 months) | F | 75 | cT4 cN2 cM1b | IV | Adenocarcinoma | Surgery (non-pulmonary) Radiotherapy/chemotherapy |
| 42 | 2 | F | 66 | pT1a pN0 | IA | Adenocarcinoma | Surgery |
*Baseline nodule category—category 4 referred to MDT at baseline, category 3 referred for repeat CT at 3 months and 12 months, category 2 referred for 12 month repeat CT.
†Participant underwent wedge resection. Clinical stage was cT1a cN0 cM0.
MDT, multidisciplinary team.